Moreover, ELISA assay and qRT-PCR demonstrated that CCL2 did not upregulate the levels of other functional ligands of CCR4, including CCL17 or CCL22, in HNSCC (Supplementary Fig. 2). This evidence concerns the gene CCL17 and head and neck squamous cell carcinoma.